Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Toscano D, Brice J, Alfaro C. Usage and perceptions of pen injectors for diabetes management: a survey of type 2 diabetes patients in the United States. J Diabetes Sci Technol. 2012;6:686–94.
2. Antalfy A, Berman K, Everitt C, Alten R, Latymer M, Godfrey CM. The adherence and outcomes benefits of using a connected, reusable auto-injector for self-injecting biologics: a narrative review. Adv Ther. 2023;40:4758–76.
3. Reis ME, Bettencourt A, Ribeiro HM. The regulatory challenges of innovative customized combination products. Front Med. 2022;9:821094.
4. Latoz C, Larkin L, Huynh-Ba K. Stability considerations for drug-device combination products-21 CFR part 4 update. AAPS Open. 2023;9:10.
5. Shire SJ. 8 – Development of Delivery Device Technology to Deal with the Challenges of Highly Viscous mAb Formulations at High Concentration. Monoclonal Antibodies. Woodhead Publishing; 2015. p. 153–62.